12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

Akshaya Bio Inc., Nuron deal

Nuron received exclusive, worldwide rights from Akshaya to Chimigen multi-antigen vaccines to treat HBV. Nuron, which said it expects...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >